CHA Vaccine Research Institute (KOSDAQ: 261780)
South Korea
· Delayed Price · Currency is KRW 3,170.00
-90.00 (-2.76%)
Dec 19, 2024, 12:45 PM KST
CHA Vaccine Research Institute Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -4,260 | -1,749 | -6,715 | -18,420 | -6,240 | -2,980 | Upgrade
|
| Depreciation & Amortization | 550.87 | 533.31 | 417.36 | 245.49 | 140.16 | 34.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.32 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | 178.87 | 40.4 | -105.84 | -125.77 | -31.7 | -47.4 | Upgrade
|
| Stock-Based Compensation | -35.01 | 118.92 | 444.39 | 451.81 | 290.03 | - | Upgrade
|
| Other Operating Activities | -160.74 | -2,286 | 1,240 | 12,783 | 2,162 | 70.91 | Upgrade
|
| Change in Accounts Receivable | 2.27 | - | - | - | - | 112.38 | Upgrade
|
| Change in Other Net Operating Assets | -2,447 | -1,951 | -469.56 | 325.6 | -273.85 | -283.24 | Upgrade
|
| Operating Cash Flow | -6,171 | -5,293 | -5,189 | -4,740 | -3,954 | -3,093 | Upgrade
|
| Capital Expenditures | -185.15 | -278.58 | -447.4 | -679.57 | -53.14 | -123.66 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -12.21 | - | -3.66 | -0.33 | - | Upgrade
|
| Investment in Securities | 16,010 | 22,221 | 4,184 | -46,780 | -6,752 | -6,158 | Upgrade
|
| Other Investing Activities | - | - | -0 | - | -66.32 | -3.31 | Upgrade
|
| Investing Cash Flow | 15,825 | 21,930 | 3,736 | -47,463 | -6,872 | -6,285 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 200 | Upgrade
|
| Long-Term Debt Issued | - | 10,000 | - | - | 23,000 | - | Upgrade
|
| Total Debt Issued | 20,000 | 10,000 | - | - | 23,000 | 200 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -3,000 | -200 | Upgrade
|
| Long-Term Debt Repaid | - | -23,671 | -116.29 | -116.29 | -8.7 | -815.51 | Upgrade
|
| Total Debt Repaid | -23,680 | -23,671 | -116.29 | -116.29 | -3,009 | -1,016 | Upgrade
|
| Net Debt Issued (Repaid) | -3,680 | -13,671 | -116.29 | -116.29 | 19,991 | -815.51 | Upgrade
|
| Issuance of Common Stock | 320.7 | 554.71 | - | 44,436 | - | 55 | Upgrade
|
| Other Financing Activities | -0 | -0 | - | - | - | 0 | Upgrade
|
| Financing Cash Flow | -3,359 | -13,117 | -116.29 | 44,320 | 19,991 | 12,035 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | 0.17 | 0.04 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - | -0 | Upgrade
|
| Net Cash Flow | 6,294 | 3,520 | -1,568 | -7,883 | 9,165 | 2,657 | Upgrade
|
| Free Cash Flow | -6,356 | -5,572 | -5,636 | -5,419 | -4,007 | -3,217 | Upgrade
|
| Free Cash Flow Margin | -1714.84% | -1894.38% | -3140.08% | -1083.82% | -5151.23% | -2550.66% | Upgrade
|
| Free Cash Flow Per Share | -237.97 | -209.32 | -213.18 | -232.42 | -223.48 | - | Upgrade
|
| Cash Interest Paid | - | - | - | - | 99.84 | 222.67 | Upgrade
|
| Cash Income Tax Paid | - | 288.65 | 85.97 | 17.07 | 2.95 | 8.49 | Upgrade
|
| Levered Free Cash Flow | -12,941 | -10,251 | -6,799 | -6,029 | -10,392 | - | Upgrade
|
| Unlevered Free Cash Flow | -12,085 | -8,607 | -5,195 | -4,703 | -9,869 | - | Upgrade
|
| Change in Net Working Capital | 7,949 | 4,956 | 1,566 | 914.16 | 7,599 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.